Transactivation of the EGF receptc and a PI3 kinase-ATF-1 pathway is involved in the upregulation of NOX1, a catalytic subunit of NADPH oxidase

被引:44
作者
Fan, CY [1 ]
Katsuyama, M [1 ]
Nishinaka, T [1 ]
Yabe-Nishimura, C [1 ]
机构
[1] Kyoto Prefectural Univ Med, Dept Pharmacol, Kamigyo Ku, Kyoto 6028566, Japan
来源
FEBS LETTERS | 2005年 / 579卷 / 05期
关键词
NOX1; NADPH oxidase; prostaglandin F-2 alpha; epidermal growth factor receptor; phosphoinositide; 3; kinase;
D O I
10.1016/j.febslet.2005.01.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously reported that hypertrophy of vascular smooth muscle cells caused by prostaglandin (PG) F-2alpha is mediated by the induction of NOX1, a catalytic subunit of NADPH oxidase that generates superoxide. The signal transduction pathway(s) involved in this process, however, remained unresolved. PGF(2alpha) enhanced the phosphorylation of the epidermal growth factor (EGF) receptor, and a selective inhibitor of EGF receptor kinase, tyrphostin AG1478, significantly suppressed PGF(2alpha)-induced NOX1 expression. AG1478 also blunted the PGF(2alpha)-induced phosphorylation of extracellular signal-regulated protein kinase (ERK)1/2 and Akt. Phosphoinositide 3 (PI3) kinase inhibitors not only reduced PGF(2alpha)-induced NOX1 expression, but also suppressed the phosphorylation of ATF-1, a transcription factor previously shown to play a key role in the induction of NOX1. Accordingly, the transactivation of the EGF receptor and the activation of ERK1/2, PI3 kinase, and ATF-1 constitute the signaling pathways involved in the upregulation of NOX1. (C) 2005 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:1301 / 1305
页数:5
相关论文
共 17 条
[1]   Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2α-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts [J].
Ahmed, I ;
Gesty-Palmer, D ;
Drezner, MK ;
Luttrell, LM .
MOLECULAR ENDOCRINOLOGY, 2003, 17 (08) :1607-1621
[2]   PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells [J].
Goncharova, EA ;
Ammit, AJ ;
Irani, C ;
Carroll, RG ;
Eszterhas, AJ ;
Panettieri, RA ;
Krymskaya, VP .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2002, 283 (02) :L354-L363
[3]   NAD(P)H oxidase - Role in cardiovascular biology and disease [J].
Griendling, KK ;
Sorescu, D ;
Ushio-Fukai, M .
CIRCULATION RESEARCH, 2000, 86 (05) :494-501
[4]   Vascular superoxide production by NAD(P)H oxidase - Association with endothelial dysfunction and clinical risk factors [J].
Guzik, TJ ;
West, NEJ ;
Black, E ;
McDonald, D ;
Ratnatunga, C ;
Pillai, R ;
Channon, KM .
CIRCULATION RESEARCH, 2000, 86 (09) :E85-E90
[5]   Oxidant signaling in vascular cell growth, death, and survival - A review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling [J].
Irani, K .
CIRCULATION RESEARCH, 2000, 87 (03) :179-183
[6]   NADPH oxidase is involved in prostaglandin F2α-induced hypertrophy of vascular smooth muscle cells -: Induction of NOX1 by PGF2α [J].
Katsuyama, M ;
Fan, CY ;
Yabe-Nishimura, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) :13438-13442
[7]  
KATSUYAMA M, IN PRESS BIOCH J
[8]   Novel gp91phox homologues in vascular smooth muscle cells -: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways [J].
Lassègue, B ;
Sorescu, D ;
Szöcs, K ;
Yin, QQ ;
Akers, M ;
Zhang, Y ;
Grant, SL ;
Lambeth, JD ;
Griendling, KK .
CIRCULATION RESEARCH, 2001, 88 (09) :888-894
[9]   The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation [J].
Mitsushita, J ;
Lambeth, JD ;
Kamata, T .
CANCER RESEARCH, 2004, 64 (10) :3580-3585
[10]   A potential role for extracellular signal-regulated kinases in prostaglandin F2α-induced protein synthesis in smooth muscle cells [J].
Rao, GN ;
Madamanchi, NR ;
Lele, M ;
Gadiparthi, L ;
Gingras, AC ;
Eling, TE ;
Sonenberg, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (18) :12925-12932